Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,246 GBX | -0.58% | +1.06% | +15.53% |
14/05 | FDA extends review of Ascendis Pharma's hormone disorder therapy | RE |
14/05 | ASTRAZENECA : Buy rating from JP Morgan | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.53% | 24TCr | |
+31.06% | 68TCr | |
+30.35% | 59TCr | |
-3.42% | 36TCr | |
+18.02% | 33TCr | |
+4.27% | 28TCr | |
+10.16% | 21TCr | |
-8.14% | 20TCr | |
+8.12% | 17TCr | |
-1.42% | 16TCr |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- LumiraDx to Partner With AstraZeneca, Everton Charity Arm For Heart And Lung Screening Hub